Association of CYP2D6 metabolizer status with mammographic density change in response to tamoxifen treatment

• Main Authors: Li, J, Czene, K, Brauch, H, Schroth, W, Saladores, P, Li, Y, Humphreys, K, Hall, P
• Other Authors: SURGERY
• Format: Article
• Published: 2020
• Subjects: cytochrome P450 2D6; tamoxifen; antineoplastic hormone agonists and antagonists; adult; aged; article; body mass; breast cancer; enzyme polymorphism; female; follow up; genetic variability; human; major clinical study; mammographic density; mammography; quantitative trait; treatment response; breast tumor; congenital malformation; genetic polymorphism; genetics; genotype; mammary gland; metabolism; middle aged; pathology; prognosis; risk factor; treatment outcome; Aged; Antineoplastic Agents, Hormonal; Breast Neoplasms; Cytochrome P-450 CYP2D6; Female; Genotype; Humans; Mammary Glands, Human; Middle Aged; Polymorphism, Genetic; Prognosis; Risk Factors; Tamoxifen; Treatment Outcome
• Online Access: https://scholarbank.nus.edu.sg/handle/10635/183197
• Institution: National University of Singapore

10.1186/bcr3495